{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:16:50Z","timestamp":1790014610114,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejpn-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejpn.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T03:50:19Z","timestamp":1480045819000},"page":"264-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Neonatal venlafaxine discontinuation syndrome: A mini-review"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-4306","authenticated-orcid":false,"given":"Jonathon","family":"Holland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2016.11.003_bib1","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2016.11.003_bib2","first-page":"37","article-title":"Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison","volume":"11","author":"Sansone","year":"2014","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.ejpn.2016.11.003_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/qjmed\/hcg062","article-title":"Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants","volume":"96","author":"Whyte","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.ejpn.2016.11.003_bib4","unstructured":"Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. https:\/\/www.medicinescomplete.com\/mc\/bnf\/current\/PHP2459-venlafaxine.htm. [Accessed 13 May 2016]."},{"key":"10.1016\/j.ejpn.2016.11.003_bib5","series-title":"Use of Venlafaxine in Pregnancy","author":"UK Teratology Information Service","year":"2016"},{"issue":"S1","key":"10.1016\/j.ejpn.2016.11.003_bib6","first-page":"20","article-title":"Neonatal movement disorder and mild encephalopathy secondary to venlafaxine withdrawal: case report and literature review. (Poster Abstract)","volume":"58","author":"Holland","year":"2016","journal-title":"Devl Med Child Neurol"},{"key":"10.1016\/j.ejpn.2016.11.003_bib7","first-page":"1370","article-title":"Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy","volume":"147","author":"De Moor","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.ejpn.2016.11.003_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1701-2163(16)32135-1","article-title":"Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome?","volume":"28","author":"Koren","year":"2006","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejpn.2016.11.003_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1440-1754.2006.00962.x","article-title":"Neonatal seizures from in utero venlafaxine exposure","volume":"42","author":"Pakalapati","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.ejpn.2016.11.003_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0028-1103296","article-title":"Placental transfer of SSRI and SNRI antidepressants and effects on the neonate","volume":"42","author":"Rampono","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejpn.2016.11.003_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/FTD.0b013e3181a58fb4","article-title":"Maternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrations","volume":"31","author":"Boucher","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ejpn.2016.11.003_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2125.2010.03714.x","article-title":"Neonatal seizures on EEG after in utero exposure to venlafaxine","volume":"70","author":"Hoppenbrouwers","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejpn.2016.11.003_bib13","first-page":"e524","article-title":"Neonatal seizures with reversible EEG changes after antenatal venlafaxine exposure","volume":"102","author":"Haukland","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ejpn.2016.11.003_bib14","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.11622\/smedj.2014061","article-title":"Myoclonic seizures in a preterm baby: is this a presentation of venlafaxine withdrawal?","volume":"55","author":"Ansary","year":"2014","journal-title":"Singap Med J"},{"key":"10.1016\/j.ejpn.2016.11.003_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00045","article-title":"Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved","author":"Renoir","year":"2013","journal-title":"Front Pharmacol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816302288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816302288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T21:44:56Z","timestamp":1542231896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379816302288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1090379816302288"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2016.11.003","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal venlafaxine discontinuation syndrome: A mini-review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}